USE OF SELEGILIN IN THE TREATMENT OF EPILECTIC CONDITIONS AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

摘要

The invention concerns the use of selegilin (L-N-(1-phenylisopropyl)-N-methyl-N-propinylamine) or its pharmaceutically usable salts in drugs with an anti-epileptic action.